カテゴリー： QYResearch, 世界

加齢黄斑変性症(AMD)治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18135）・商品コード：DATA909X18135
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、加齢黄斑変性症(AMD)治療の世界市場について調査・分析し、加齢黄斑変性症(AMD)治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ウェットAMD、ドライAMD）、用途別（病院、クリニック、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の加齢黄斑変性症(AMD)治療市場動向
・主要企業別マーケットシェア
・加齢黄斑変性症(AMD)治療の種類別市場規模2014-2019
（ウェットAMD、ドライAMD）
・加齢黄斑変性症(AMD)治療の用途別市場規模2014-2019
（病院、クリニック、研究所、その他）
・加齢黄斑変性症(AMD)治療の北米市場：主要企業・種類別/用途別市場規模
・加齢黄斑変性症(AMD)治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・加齢黄斑変性症(AMD)治療の中国市場：主要企業・種類別/用途別市場規模
・加齢黄斑変性症(AMD)治療の日本国内市場：主要企業・種類別/用途別市場規模
・加齢黄斑変性症(AMD)治療の東南アジア市場：主要企業・種類別/用途別市場規模
・加齢黄斑変性症(AMD)治療のインド市場：主要企業・種類別/用途別市場規模
・加齢黄斑変性症(AMD)治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Amgen Inc.、Bausch Health Companies, Inc.、F. Hoffmann-La Roche Ltd.、Novartis AG、Regeneron Pharmaceuticals Inc.）
・加齢黄斑変性症(AMD)治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
In 2018, the global Age-Related Macular Degeneration (AMD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Age-Related Macular Degeneration (AMD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Age-Related Macular Degeneration (AMD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
…

Market segment by Type, the product can be split into
Wet AMD
Dry AMD

Market segment by Application, split into
Hospital
Clinic
Research Institute
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Age-Related Macular Degeneration (AMD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Age-Related Macular Degeneration (AMD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Age-Related Macular Degeneration (AMD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size
2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2019-2025)
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by by Players
3.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
5.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America
5.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
5.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

6 Europe
6.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe
6.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
6.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

7 China
7.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China
7.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
7.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

8 Japan
8.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan
8.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
8.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
9.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

10 India
10.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India
10.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
10.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America
11.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
11.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application

12 International Players Profiles
12.1 Amgen Inc.
12.1.1 Amgen Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
12.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019))
12.1.5 Amgen Inc. Recent Development
12.2 Bausch Health Companies, Inc.
12.2.1 Bausch Health Companies, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
12.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
12.2.5 Bausch Health Companies, Inc. Recent Development
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 F. Hoffmann-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Company Details
12.4.2 Company Description and Business Overview
12.4.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
12.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
12.4.5 Novartis AG Recent Development
12.5 Regeneron Pharmaceuticals Inc.
12.5.1 Regeneron Pharmaceuticals Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
12.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
12.5.5 Regeneron Pharmaceuticals Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Age-Related Macular Degeneration (AMD) Therapeutics Key Market Segments
Table Key Players Age-Related Macular Degeneration (AMD) Therapeutics Covered
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Wet AMD Figures
Table Key Players of Wet AMD
Figuer Dry AMD Figures
Table Key Players of Dry AMD
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Research Institute Case Studies
Figure Other Case Studies
Figure Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions 2014-2019
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions 2014-2019
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by by Players (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by by Players in 2018
Table Global Age-Related Macular Degeneration (AMD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product/Solution/Service
Table Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Application in 2018
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Figure India Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Figure Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2018-2019)
Table Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type 2014-2019
Table Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application 2014-2019
Table Amgen Inc. Company Details
Table Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business 2014-2019 (Million US$)
Figure Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
Table Amgen Inc. Recent Development
Table Bausch Health Companies, Inc. Company Details
Table Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business 2014-2019 (Million US$)
Figure Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
Table Bausch Health Companies, Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table Regeneron Pharmaceuticals Inc. Company Details
Table Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business 2014-2019 (Million US$)
Figure Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
Table Regeneron Pharmaceuticals Inc. Recent Development
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Regions in 2025
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Product (2019-2025)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Product in 2025
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2019-2025)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Amgen Inc.、Bausch Health Companies, Inc.、F. Hoffmann-La Roche Ltd.、Novartis AG、Regeneron Pharmaceuticals Inc.

★調査レポート[加齢黄斑変性症(AMD)治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18135)販売に関する免責事項を必ずご確認ください。
★調査レポート[加齢黄斑変性症(AMD)治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 高密度焦点式超音波（HIFU）治療の世界市場：規模・現状・予測2019-2025
    DATA909X18541 / QYResearch / 2019年11月25日 / ※当調査レポートでは、高密度焦点式超音波（HIFU）治療の世界市場について調査・分析し、高密度焦点式超音波（HIFU）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（超音波ガイド、MRガイド）、用途別（前立腺癌、子宮筋腫、神経障害、エステティック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の高密度焦点式超音波（HIFU）治療市場動向 ・主要企業別マーケットシェア ・高密度焦点式超音波（HIFU）治療の種類別市場規模2014-2019 （超音波ガイド、MRガイド） ・高密度焦点式超音波（HIFU）治療の用途別市場規模2014-2019 （前立腺癌、子宮筋腫、神経障害、エステティック、その他） ・高密度焦点式超音波（HIFU）治療の北米市場：主要企業・種類別/用途別市場規模 ・高密度焦点式超音波（HIFU）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...High-intensity focused ultrasound (HIFU) is a rapidly maturing technology with diverse clinical applications. In the field of oncology, the use of HIFU to non-invasively cause tissue necrosis in a defined target, a technique known as focused ultrasoundsurgery (FUS), has considerable potential for tumour ablation.In 2018, the global High-intensity Focused Ultrasound (HIFU) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global High-intensity Focused Ultrasound (HIFU) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are...

    • ◆H&Iグローバルリサーチのお客様（例）◆